Metadon Nordic Drugs (Methadone Hydrochloride)

Methadone works by binding to mu‑opioid receptors in the brain and spinal cord, acting as a full agonist. This activation blocks pain signals and suppresses the physiological response to opioid withdrawal. Additionally, methadone inhibits the reuptake of serotonin and norepinephrine, which contributes to its analgesic effect and helps maintain stable plasma levels with once‑daily dosing.

The appropriate dose of Metadon is individualized and determined by a qualified prescriber based on the patient’s clinical condition, prior opioid exposure, and response to therapy. Dosage adjustments are made gradually to achieve therapeutic goals while minimizing side effects. Patients should follow the prescribing clinician’s instructions and never alter the dose without medical guidance.

Data on methadone use in pregnancy and lactation are limited, and the drug is classified as a potential risk. It may be prescribed during pregnancy only when the benefit to the mother outweighs potential risks to the fetus. Methadone does pass into breast milk, so breastfeeding mothers should discuss risks and alternatives with their healthcare provider.

To request Metadon, submit an enquiry on the product page at gnhindia.com, specifying the required quantity. GNH India works with hospitals, pharmacies, and procurement teams worldwide, and will ask for trade or institutional credentials. After verification, the sales team provides pricing, availability, shipping details—including any required cold‑chain handling—and assists with import documentation.

Both methadone (Metadon) and buprenorphine are used for opioid dependence, but they differ in pharmacology. Methadone is a full mu‑opioid agonist with a longer half‑life, requiring daily dosing and careful monitoring for respiratory depression. Buprenorphine is a partial agonist with a ceiling effect on respiratory depression, often allowing for less frequent dosing and a lower overdose risk. Choice depends on patient history, treatment setting, and clinician judgment.

Metadon should be stored at room temperature, below 25 °C. Keep the product in its original packaging, protect it from moisture and direct sunlight, and ensure the container is tightly closed. Do not store in a refrigerator or freezer unless the manufacturer provides specific instructions.

Metadon is administered orally. The tablet or capsule should be swallowed whole with a full glass of water. It is not intended for crushing, chewing, or dissolving unless specifically directed by a healthcare professional. Dosing times are usually once daily, but the exact schedule is determined by the prescribing clinician.

The most serious risks include respiratory depression, which can be life‑threatening, especially after dose escalation or when combined with other depressants. Methadone can also prolong the QT interval, increasing the chance of cardiac arrhythmias. Overdose, severe hypotension, and rare cases of adrenal insufficiency are additional critical concerns that require immediate medical attention.

Metadon is contraindicated in individuals with known hypersensitivity to methadone or any component of the formulation, patients with severe respiratory depression, and those taking monoamine oxidase inhibitors (MAOIs) within 14 days of starting therapy. Caution is also advised for patients with significant cardiac disease, uncontrolled asthma, or a history of severe constipation.